Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression

Journal of Experimental Medicine

Volumn 188, Issue 10, 1998, Pages 1795-1802

  Yeh, Jung Hua ^a,b   Hsu, Shu Ching ^b,c   Han, Shou Hwa ^a   Lai, Ming Zong ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Fas; Fas associated death domain protein; FLIP; Mitogen activated protein kinase kinase

Indexed keywords

CELL PROTEIN; FAS ANTIGEN; INHIBITOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE;

ADOLESCENT; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CONCANAVALIN A; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION;

EID: 0032539007     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.10.1795     Document Type: Article

References (48)

1. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
2. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
3. Boldin, M.P., E.E. Varfolomeev, Z. Pancer, I.L. Mett, J.H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795-7798.
4. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, et al. 1996. Flice, a novel FADD-homologue ICE/ CED-3-like protease, is recruited to the CD95(Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
5. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/ FADD-interacting protease in Fas/APO-1-and TNF receptor-induced cell death. Cell. 85:803-815.
6. Medema, J.P., C. Scaffidi, F.C. Kischkel, A. Shevchenko, M. Mann, P.H. Krammer, and M.E. Peter. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:2794-2804.
7. Enari, M., R.V. Talanian, W.W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like protease during Fas-mediated apoptosis. Nature. 380:723-726.
8. Hirata, H., A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai, T. Okazaki, K. Yamamoto, and M. Sasada. 1998. Caspases are activated in a branched protease cascade and control distinct downstream process in Fas-induced apoptosis. J. Exp. Med. 187:587-600.
9. Chinnaiyan, A.M., C.G. Tepper, M.F. Seldin, K. O'Rourke, F.C. Kischkel, S. Hellbardt, P.H. Krammer, M.E. Peter, and V.M. Dixit. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/Apo-1) and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271:4961-4965.
10. Chinnaiyan, A.M., K. O'Rourke, G.-L. Yu, R.H. Lyons, M. Garg, D.R. Duan, L. Xing, R. Gentz, J. Ni, and V.M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science. 274: 990-992.
11. Walczak, H., M.A. Degli-Esposti, R.S. Johnson, P.J. Smolak, J.Y. Waugh, N. Boiani, M.S. Timour, M.J. Gerhart, K.A. Schooley, C.A. Smith, et al. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16:5386-5397.
12. Chaudhary, P.M., M. Eby, A. Jasmin, A. Bookwalter, J. Murray, and L. Hood. 1997. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity. 7:821-830.
13. Schneider, P., M. Thome, K. Burns, J.-L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, and J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity. 7:831-836.
14. Yeh, W.-C., J.L. de la Pompa, M.E. McCurrach, H.-B. Shu, A.J. Elia, A. Shahinian, M. Ng, A. Wakeham, W. Khoo, K. Mitchell, et al. 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 279:1954-1958.
15. Zhang, J., D. Cado, A. Chen, N.H. Kabra, and A. Winoto. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature. 392:296-300.
16. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.-L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature. 388:190-195.
17. Goltsev, Y.V., A.V. Kovalenko, E. Arnold, E.E. Varfolomeev, V.M. Brodianskii, and D. Wallach. 1997. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272:19641-19644.
18. Hu, S., C. Vincenz, J. Ni, R. Gentz, and V.M. Dixit. 1997. I-FLICE, a novel inhibitor tumor necrosis factor receptor-1 and CD-95-induced apoptosis. J. Biol. Chem. 272:17255-17257.
19. Shu, H.-B., D.R. Halpin, and D.V. Goeddel. 1997. Casper is a FADD-and caspase-related inducer of apoptosis. Immunity. 6:751-763.
20. Srinivasula, S.M., M. Ahmad, S. Ottlie, F. Bullrich, S. Banks, Y. Wang, T. Fernandes-Alnemri, C.M. Croce, G. Litwack, K.J. Tomaselli, et al. 1997. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272:18542-18545.
21. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.-L. Bodmer, M. Schroter, et al. 1997. Viral FLICE-inhibitory proteins (FLIPS) prevent apoptosis induced by death receptor. Nature. 386:517-521.
22. Klas, C., K.-M. Debatin, R.R. Jonker, and P.H. Krammer. 1993. Activation interferes with APO-1 pathway in mature human T cells. Int. Immunol. 6:625-630.
23. Holmstrom, T.H., S.C. Chow, I. Elo, E.T. Coffey, S. Orrenius, L. Sistonen, and J.E. Eriksson. 1998. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J. Immunol. 260:2626-2636.
24. McLeod, J.D., L.S.K. Walker, Y.I. Patel, G. Boulougouris, and D.M. Sansom. 1998. Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. J. Immunol. 160:2072-2079.
25. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.
26. Hsueh, Y.-P., and M.-Z. Lai. 1995. JNK but not MAP kinase is sensitive to cAMP in T lymphocytes. J. Biol. Chem. 270:18094-18098.
27. Lee, M.-R., M.-L. Liou, M.-L. Liou, Y.-F. Yang, and M.-Z. Lai. 1993. cAMP analogs prevent activation-induced apoptosis of T cell hybridoma. J. Immunol. 151:5208-5217.
28. Tewari, M., L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D.R. Beidler, G.G. Poirier, G.S. Salvesen, and V.M. Dixit. 1995. Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:801-809.
29. Mansour, S.J., W.T. Matten, A.S. Hermann, J.M. Candia, S. Rong, K. Fukasawa, G.F. Vande Woude, and N.G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 265:966-970.
30. Jiang, Y., C. Chen, Z. Li, W. Guo, J.A. Gegner, S. Lin, and J. Han. 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271:17920-17926.
31. Lai, M.-Z., Y.-J. Jang, L.-K. Chen, and M.L. Gefter. 1990. Restricted V-(D)-J junctional regions in the T cell response to λ repressor: identification of residues critical for antigen recognition. J. Immunol. 144:4851-4856.
32. Hsueh, Y.-P., H.-E. Liang, S.-Y. Ng, and M.-Z. Lai. 1997. CD28 costimulation activates CREB in T lymphocytes. J. Immunol. 158:85-93.
33. Nicoletti, I., G. Migliorati, M.C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:271-279.
34. Hsu, S.-C., C.-C. Wu, T.-Y. Luh, C.-K. Chou, S.-H. Han, and M.-Z. Lai. 1998. Apoptotic signal of Fas is not mediated by ceramide. Blood. 91:2658-2663.
35. Alessi, D.R., A. Cuenda, P. Cohen, D.T. Dudley, and A.R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
36. del Carmen Ruiz-Ruiz, M., M. Izquierdo, G. de Murcia, and A. Lopez-Rivas. 1997. Activation of protein kinase C attenuates early signals in Fas-mediated apoptosis. Eur. J. Immunol. 27:1442-1450.
37. Hauser, P., G. Papoff, A. Eramo, K. Reif, D.A. Cantrell, and G. Ruberti. 1998. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. Eur. J. Immunol. 28:57-69.
38. Nishimura, Y., A. Ishii, Y. Kobayashi, Y. Yamasaki, and S. Yonehara. 1995. Expression and function of mouse Fas antigen on immature and mature T cells. J. Immunol. 154:4395-4403.
39. Hitoshi, Y., J. Lorens, S. Kitada, J. Fisher, M. LaBarge, H.Z. Ring, U. Francke, J.C. Reed, S. Kinoshita, and G.P. Nolan. 1998. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 8:461-471.
40. Rafaeli, Y., L.V. Parijs, C.A. London, J. Tschopp, and A.K. Abbas. 1998. Biochemical mechanism of IL-2 regulated Fas-mediated T cell apoptosis. Immunity. 8:615-623.
41. Wong, B., J. Arron, and Y. Choj. 1997. T cell receptor signals enhance susceptibility to Fas-mediated apoptosis. J. Exp. Med. 186:1939-1944.
42. Hornung, F., L. Zheng, and M.J. Lenardo. 1997. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J. Immunol. 159:3816-3822.
43. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA. 90:5889-5892.
44. Cobb, M.H., and E.J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14843-14846.
45. Xia, Z., M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinase on apoptosis. Science. 270:1326-1331.
46. Cuvillier, O., G. Pirianov, B. Kleuser, P.G. Vanek, O.A. Coso, J.S. Gutkind, and S. Spiegel. 1996. Suppression of ceramide-mediated cell death by sphingosine-1-phosphate. Nature. 381:800-803.
47. Sheng, Z., K. Knowlton, J. Chen, M. Hoshijima, J.H. Brown, and K.R. Chien. 1997. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J. Biol. Chem. 272:5783-5791.
48. Widmann, C., S. Gibson, and G.L. Johnson. 1998. Caspase-dependent cleavage of signaling protein during apoptosis. J. Biol. Chem. 273:7141-7147.